Alzheimer's Disease
Healio Minute Podcast, Neurology Edition: Top Headlines - Week of August 15, 2022
In this edition, light stimulation may help delay Alzheimer’s progression; sleep EEGs may predict future disease and mortality; updated data on the prevalence of tinnitus and more.
SYNAPS Dx opens lab to support launch of minimally invasive AD diagnostic test
SYNAPS Dx has announced the opening of a new laboratory to support the launch of DISCERN, a minimally invasive diagnostic test to identify Alzheimer’s disease in people with dementia.
NIH awards $3.35M to Oligomerix for development of tau-targeting AD therapy
The NIH has awarded $3.35 million to Oligomerix Inc. for clinical development of its lead program, OLX-07010, an oral tau self-association small molecule inhibitor for the treatment of early-stage Alzheimer’s disease.
Leisure activities may lower risk for Alzheimer's disease, dementia
Leisure activities, such as reading a book, doing yoga and spending time with family and friends, were associated with a decreased risk for all-cause dementia, Alzheimer's disease and vascular dementia, researchers reported in Neurology.
NIH to fund development, testing of robots to aid in Alzheimer's disease care
The University of New Hampshire announced it will receive a 5-year, $2.8 million grant from NIH to develop and test social assistive robots to elevate at-home care for people with Alzheimer’s disease and dementia.
Gut-based neurotoxin triggers inflammation associated with Alzheimer's disease
A neurotoxin derived from bacteria in the gastrointestinal tract has been identified as a major contributor to Alzheimer’s disease, researchers reported in Frontiers in Neurology.
AF a risk factor for dementia in adults younger than 70 years
Atrial fibrillation conferred elevated risk for dementia in adults younger than 70 years, according to study findings published in the Journal of the American Heart Association.
Diagnostic labels varied in nearly 40% of AD study population using different guidelines
SAN DIEGO — Diagnostic outcomes varied in nearly 40% of a study population when different criteria were used to diagnose Alzheimer’s disease, per a presenter at the Alzheimer’s Association International Conference.
Light stimulation may help delay AD progression, more research needed in older adults
SAN DIEGO — Light exposure and stimulation of the locus coeruleus may be a promising way to delay Alzheimer’s disease progression, according to a presenter at the Alzheimer’s Association International Conference.
CSF biomarkers support AD diagnosis in nearly 90% of clinical cases
SAN DIEGO — Cerebrospinal fluid biomarkers supported the clinical diagnosis of Alzheimer’s disease in a small cohort of patients, per a poster presentation at the Alzheimer’s Association International Conference.